Literature DB >> 31578170

Interstitial lung disease: perhaps unclassifiable, but not untreatable.

Justin M Oldham1.   

Abstract

Entities:  

Year:  2019        PMID： 31578170     DOI： 10.1016/S2213-2600(19)30343-1

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN： 2213-2600            Impact factor:   30.700


× No keyword cloud information.
  2 in total

1.  Home spirometry to assess efficacy of pirfenidone in progressive unclassifiable interstitial lung disease: better the devil you know than the devil you don't.

Authors:  Giacomo Sgalla; Pier-Valerio Mari; Luca Richeldi
Journal:  Ann Transl Med       Date:  2020-12

Review 2.  Progression in the Management of Non-Idiopathic Pulmonary Fibrosis Interstitial Lung Diseases, Where Are We Now and Where We Would Like to Be.

Authors:  Tinne Goos; Laurens J De Sadeleer; Jonas Yserbyt; Geert M Verleden; Marie Vermant; Stijn E Verleden; Wim A Wuyts
Journal:  J Clin Med       Date:  2021-03-23       Impact factor: 4.241
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.